LONDON, Jan 15 (Reuters) - U.S. regulators are proposing
to cap the amount of nicotine in cigarettes at non-addictive
levels, in a potential world-first that could curb smoking and
hit tobacco industry earnings.
The U.S. Food and Drug Administration (FDA), which regulates
products containing nicotine, a highly addictive drug, first
raised the idea of such a cap in 2018. It said this would save
lives by preventing smoking-related disease and death, by taking
away the chemical that keeps smokers hooked.
On Wednesday, it proposed capping the level of nicotine at
0.7 milligrams per gram of tobacco in cigarettes and other
combustible tobacco products, such as cigars and roll your own
tobacco. Alternatives like vapes, nicotine pouches and heated
tobacco would not be affected by the cap.
That would mean cigarettes would no longer deliver the
nicotine hit desired by many smokers, encouraging them to quit
or switch to alternatives, while young people could be less
likely to take up smoking in the first place.
"This proposal allows for the start of an important
conversation about how we meaningfully tackle one of the
deadliest consumer products in history and profoundly change the
landscape of tobacco product use in the United States," said FDA
Center for Tobacco Products director Brian King.
The agency's modelling predicted such a rule could prevent
48 million youth or young adults from starting smoking, and more
than 12.9 million people who smoke would give up within one year
of it coming into effect. That would rise to 19.5 million within
five years, it said.
That would threaten the profit engine of large tobacco
companies like British American Tobacco ( BTI ) and
Marlboro-maker Altria ( MO ). While they are growing sales from
alternatives like vapes, the vast majority of their revenues
still come from tobacco.
They did not immediately respond to a request for comment.
The FDA's proposal is "truly game-changing", said Yolanda
Richardson, President and CEO of the Campaign for Tobacco-Free
Kids, urging President-elect Donald Trump to finalise and
implement the rule. He takes office on Jan. 20.
The public will have until September to provide comments on
the proposal, the FDA said.